Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

Translated title of the contribution: Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

M. Peipp, T. Schneider-Merck, M. Dechant, T. Beyer, J.J. Lammerts van Bueren, W.K. Bleeker, P.W.H.I. Parren, J.G.J. van de Winkel, T. Valerius

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
Original languageUndefined/Unknown
Pages (from-to)4338-4345
Number of pages8
JournalJournal of Immunology
Volume180
Issue number6
Publication statusPublished - 2008

Cite this